par Amson, Robert ;Sigaux, François;Przedborski, Serge ;Flandrin, Georges;Givol, David;Telerman, Adam
Référence Proceedings of the National Academy of Sciences of the United States of America, 86, 22, page (8857-8861)
Publication Publié, 1989
Article révisé par les pairs
Résumé : We measured the human pim-1 protooncogene (PIM) expression during fetal development and in hematopoietic malignancies. Our data indicate that during human fetal hematopoiesis the 33-kDa pim product, p33pim, is highly expressed in the liver and spleen. In contrast, at the adult stage it is only slightly expressed in circulating granulocytes. Out of 70 hematopoietic malignancies analyzed, 51 patients and 19 cell lines, p33pim was overexpressed in ~30% of the samples, particularly in myeloid and lymphoid acute leukemias. This overexpression was unrelated to any stage of cellular differentiation and was not due to gene rearrangement or amplification. These results imply a physiological role of the pim-1 protooncogene during hematopoietic development and a deregulation in various leukemias.